EydisBio Inc.
- Biotech or pharma, therapeutic R&D
- Academic, tech transfer
EydisBio is a Duke University spin out focused on the development of small molecule inhibitors targeting TAK1. TAK1 is an inflammatory kinase central to TNF signal pathways and autoimmune diseases.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}